s health state.

2 trials

Sponsors

Warakukai Incorporated Medical Institution

Conditions

Anxious-depressiveAnxious-depressive attack

Unknown Phase

A randomized, double-blind, adjustable-dose, parallel-group study of haloperidol or aripiprazole for the treatment of Anxiety-Depressed Attack

RecruitingJPRN-UMIN000033291

Warakukai Incorporated Medical InstitutionAnxious-depressive attack

Start: 2018-02-06Target: 40Updated: 2026-06-29

A randomized, double-blind, adjustable-dose, parallel-group study of mosapramine or aripiprazole for the treatment of Anxiety-Depressed Attack.

Active, not recruitingJPRN-UMIN000028305

Warakukai Incorporated Medical InstitutionAnxious-depressive

Start: 2017-08-21Target: 40Updated: 2026-06-29